As of 2025-07-12, the Intrinsic Value of Titan Medical Inc (TMD.TO) is 3.44 CAD. This TMD.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.80 CAD, the upside of Titan Medical Inc is 330.50%.
The range of the Intrinsic Value is 2.70 - 4.84 CAD
Based on its market price of 0.80 CAD and our intrinsic valuation, Titan Medical Inc (TMD.TO) is undervalued by 330.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 2.70 - 4.84 | 3.44 | 330.5% |
| DCF (Growth 10y) | 3.12 - 5.55 | 3.97 | 396.2% |
| DCF (EBITDA 5y) | 4.88 - 6.32 | 5.56 | 594.7% |
| DCF (EBITDA 10y) | 4.71 - 6.77 | 5.63 | 604.3% |
| Fair Value | -0.78 - -0.78 | -0.78 | -196.98% |
| P/E | (6.09) - 9.36 | 1.00 | 25.5% |
| EV/EBITDA | (1.75) - 5.26 | 1.66 | 108.1% |
| EPV | (5.11) - (8.13) | (6.62) | -927.7% |
| DDM - Stable | (1.15) - (2.82) | (1.99) | -348.2% |
| DDM - Multi | 2.01 - 4.08 | 2.72 | 239.9% |
| Market Cap (mil) | 35.40 |
| Beta | 1.41 |
| Outstanding shares (mil) | 44.25 |
| Enterprise Value (mil) | 31.59 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.15% |
| Cost of Debt | 5.00% |
| WACC | 7.98% |